VERTICAL
Shortlist
ANA: header image. AI-generated image (Grok Imagine).

File 017 · Clinical

ANA

Candidate sources on antinuclear antibody testing and interpretation. A positive ANA is not a diagnosis. Nothing in this file is a verified clinical claim.

A positive ANA is not a diagnosis.

62 records · 11 fields · 2000–2026

AI-generated image (Grok Imagine)

Makers in this file

Records

62 / 62 sources

Facets for table, plates, and tiles

Field

Decade

Maker

No.RecordMakerYearFieldSICNAICS
12019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus 67%8071621511
2American College of Rheumatology: Five Things Physicians and Patients Should Question 67%8071621511
3Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine 67%8071621511
4Choosing Wisely's Treatments, Tests that Pediatric Rheumatologists and Patients Should Question 67%8071621511
5Choosing wisely: the American College of Rheumatology's Top 5 list of things physicians and patients should question 67%8071621511
6Diagnosis of Systemic Lupus Erythematosus 67%8071621511
7International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies 67%8071621511
8Rheumatologic Tests: A Primer for Family Physicians 67%8071621511
9Sjögren's Disease 67%8071621511
10Antinuclear antibody panel 67%8071621511
11ANA (Antinuclear Antibody) Test: MedlinePlus Medical Test 67%8071621511
12ANA Blood Test: Order, Results & What They Mean 67%8071621511
13Antinuclear Antibodies (ANA), Serum 67%8071621511
14Antinuclear Antibodies (ANA), Serum 67%8071621511
15Antinuclear Antibodies, HEp-2 Substrate, IgG, Serum 67%8071621511
16Antinuclear Antibodies, HEp-2 Substrate, IgG, Serum 67%8071621511
17Antinuclear Antibody (ANA) With HEp-2 Substrate by IFA 67%8071621511
18Antinuclear Antibody (ANA) with HEp-2 Substrate, IgG by IFA 67%8071621511
19Antinuclear antibody (ANA) testing options 67%8071621511
20Connective Tissue Diseases - Systemic Autoimmune Rheumatic Diseases 67%8071621511
21Department of Pathology and Laboratory Medicine Reflex Test List 2025 67%8071621511
22Systemic Lupus Erythematosus - SLE 67%8071621511
23Tests for Autoimmune Diseases 67%8071621511
24Applying Choosing Wisely: Antinuclear Antibody (ANA) and Sub-Serology Testing in a Safety Net Hospital System 67%8071621511
25ANA Test 67%8071621511
26ANA test 67%8071621511
27Decoding the ANA: A Guide to ANA Testing 67%8071621511
28A Personal View on My Lupus Diagnosis 67%8071621511
29ANA Curiousity question? 67%8071621511
30Britt Clark | My Lupus Story 67%8071621511
31I Was Diagnosed With Lupus At Age 30 67%8071621511
32My Autoimmune Journey: From 1:5120 to 1:320 ANA 67%8071621511
33Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus 67%8071621511
34Antinuclear antibody-negative systemic lupus erythematosus: How many patients and how to identify? 67%8071621511
35Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease 67%8071621511
36High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease 67%8071621511
37Increasing Prevalence of Antinuclear Antibodies in the United States 67%8071621511
38Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent-onset disease 67%8071621511
39Longitudinal antinuclear antibody titers in systemic lupus erythematosus and other rheumatic diseases 67%8071621511
40Measurement of antinuclear antibodies: assessment of different test systems 67%8071621511
41Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases 67%8071621511
42Repeat Testing of Antibodies and Complements in Systemic Lupus Erythematosus: When Is It Enough? 67%8071621511
43Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014-2015 67%8071621511
44Antinuclear antibodies in healthy people and non-rheumatic diseases – diagnostic and clinical implications 67%8071621511
45Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective 67%8071621511
46The Art of Interpreting Antinuclear Antibodies (ANAs) in Everyday Practice 67%8071621511
47The International Consensus on ANA Patterns (ICAP) in 2021—The 6th Workshop and Current Perspectives 67%8071621511
48Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases 67%8071621511
49AC-2 Nuclear dense fine speckled 67%8071621511
50ANA Patterns 50%8071621511
51Antinuclear Antibodies (ANA) 67%8071621511
52Methodology of Testing for Antinuclear Antibodies (ACR Position Statement) 67%8071621511
53Advisory Panel Guidance on Minimum Retesting Intervals for Lab Tests 67%8071621511
54Identifying antinuclear antibody positive individuals at risk for developing systemic autoimmune disease: development and validation of a real-time risk model 67%8071621511
55Review for the generalist: The antinuclear antibody test in children - When to use it and what to do with a positive titer 67%8071621511
56Prevalence and sociodemographic correlates of antinuclear antibodies in the United States 67%8071621511
57Anti-DFS70 Antibodies for Differentiating Systemic Autoimmune Rheumatic Disease in Patients with Positive ANA Tests: A Systematic Review and Meta-Analysis 67%8071621511
58Diagnostic performance of anti-DFS70 antibodies in excluding systemic lupus erythematosus diagnosis: An updated systematic review and meta-analysis 67%8071621511
59Evaluation of Progression From Preclinical to Systemic Autoimmune Rheumatic Disease: Novel Use of the European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria as an Outcome Measure 67%8071621511
60Historical Perspective on Antinuclear Antibody Testing 67%8071621511
61Antinuclear Antibody Testing: Gold Standard Revisited 67%8071621511
62Prescription medication use and antinuclear antibodies in the United States, 1999-2004 67%8071621511

File Notes

How this file was kept

Methodology
All 62 records are draft candidates. Eight duplicates were consolidated on the way in, and ten were added from a gap search on 2026-09-28. A positive ANA is not a diagnosis, and a change in titer alone is not proof of a treatment effect. Claim verification is still pending. Twenty-four records have no publication date and show as n.d.
Sourcing
Assembled 2026-09-28 from the ANA candidate collection (schema 0.3). Publishers, links, and summaries are the ones in that collection. They have not been re-checked against the source for this filing.
Provenance
File 017. 62 candidate sources. Slug ana.